The 61st Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA - Hynes Convention Center October 30 - November 2, 2010

[Guest guest]

http://www.digitaljournal.com/pr/117474

The 61st Annual Meeting of the American Association for the Study of Liver

Diseases

Boston, MA - Hynes Convention Center October 30 - November 2, 2010

PR Newswire

ALEXANDRIA, Va., Sept 20 /PRNewswire/ -- The Liver Meeting® is the premier

meeting in the science and practice of hepatology, including the latest findings

on new drugs, novel treatments, and the results from pilot and multicenter

studies.

Approximately 10 percent of Americans have some form of liver disease, and the

diseases strike disproportionately among certain populations but mostly

regardless of lifestyle choices. There are now numerous treatments for both

hepatitis B and C, and screening, treatment, and prevention of hepatitis remain

important issues. Liver cancer is one of the few cancers growing in incidence,

and the obesity epidemic has dire consequences for the nation's liver health and

wellness.

The 2047 abstracts addressing these issues that will be presented are available

to members of the press at our website (www.aasld.org), including 258 abstracts

that will be presented in oral sessions.

Boston, MA – October 30 - November 2, 2010

Poster Presentations:

October 30 – November 2

Oral Presentations:

October 31 – November 2

An AASLD President's press conference highlighting key abstracts and issues

presented at the Liver Meeting® is scheduled for Saturday, October 30 at 4:00

pm.

This year's President's Choice Lecture will be given by the 14th Assistant

Secretary for Health for the US Department of Health and Human Services, Dr.

Koh. The lecture will focus on the findings from the Institute of

Medicine (IOM) study, " Hepatitis and Liver Cancer: A National Strategy for

Prevention and Control of Hepatitis B and C. " Dr. Koh has provided visionary and

extraordinary leadership in assembling a US Department of Health and Human

Services-wide team to begin to address the epidemic of viral hepatitis in the

US. He will speak about his efforts and the steps the US administration is

taking in response to the IOM report. AASLD has worked jointly with the Trust

for America's Health (TFAH) to translate the IOM report into language that could

be used to affect appropriations to support research and health care delivery

for liver disease and also to be used in future legislation to make the

screening, early detection, and treatment of viral hepatitis a reality. The

AASLD/TFAH report will focus on the policy issues that need to be addressed to

advance the implementation of the IOM's work.

Founded in 1950, AASLD is the leading organization of scientists and healthcare

professionals committed to preventing and curing liver disease. AASLD has grown

into an international society responsible for all aspects of hepatology, and our

annual meeting attracts 7,500 physicians, surgeons, researchers, and allied

health professionals from around the world.

Please contact AASLD at 703-299-9766 for information about the above

presentations, or to receive any additional information about The Liver Meeting®

– or visit our website at www.aasld.org.

This release was issued through The Xpress Press News Service, merging e-mail

and satellite distribution technologies to reach business analysts and media

outlets worldwide. For more information, visit http://www.XpressPress.com.

Contact:

Bologna, gbologna@...

Ann Haran, aharan@...

SOURCE American Association for the Study of Liver Diseases (AASLD)

Read more: http://www.digitaljournal.com/pr/117474#ixzz10A7bjDLp